• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of Immune Escape from NK cell in Melanoma

Research Project

Project/Area Number 14570812
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Dermatology
Research InstitutionKumamoto University

Principal Investigator

KAGESHITA Toshiro  Kumamoto University, School of Medicine, Department of Dermatology, Associate Professor, 大学院・医学薬学研究部, 助教授 (20152605)

Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2003: ¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 2002: ¥2,000,000 (Direct Cost: ¥2,000,000)
Keywordsmelanoma / NK cell / immune escape / MICA / MICB
Research Abstract

One of the larger concernsin melanoma T cell based immunotherapy is the immune escape phenomenon resulting from loss of melanoma associated antigens and/or HLA class I. The head investigator has been analyzing the mechanisms of down regulation of HLA class I in melanocytic cells.
HLA class I was down regulated in melanoma lesions, which results in no T cell infiltration in such lesions. Theoretically loss of HLA class I in melanoma cells allows NK cell infiltration. However, most of the melanoma lesions show neither T cell nor NK cell infiltration. These data suggest that melanoma cells can escape from NK cell attack.
In the present study, analysis of immune escape from NK cell in melanoma was investigated using monoclonal antibodies to MHC class I chain-related molecule A and B (MICA and MICB), which are ligands for the newly cloned NK cell activating receptor NKG2D.
The head investigator found the following points :
1)Expression of MICA in culture human melanoma cell lines
Ten of 16 human … More melanoma cell lines were shown to be MICA positive by ELISA.
2)Expression of MICA in melanocytic tumors
Expression of MICA in melanocytic lesions was investigated immunohistochemically using frozen melanocytic nevus, and primary and metastatic melanoma lesions. MICA was not expressed in melanocytic nevus, however it was expressed in melanoma lesions. MICA was expressed in 30%, 60%, and 20% of radial growth phase, vertical growth phase, and metastatic lesions, respectively.
3)Selection of monoclonal antibody to MICB which can react with formalin-fixed tissue section
The monoclonal antibody to MICA did not react with formalin-fixed tissue sections. Therefore, I tried to find a monoclonal antibody to MICB which can react with formalin-fixed tissue section from more than 10 antibodies to MICB. We were able to select one antibody to MICB that could react with formalin-fixed tissue sections using the retrieval antigen method.
These data will facilitate the analysis of immune escape from NK cell in melanoma and further research project is under going at my laboratory. Less

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (30 results)

All Other

All Publications (30 results)

  • [Publications] Kageshita T.: "Widespread expression of parathyroid hormone-related peptide in melanocytic cell."Brit J Dermatol.. 143. 533-538 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takata M.: "Two cases of unusual acral melanocytic tumors : Demonstration of molecular cytogenetics as a diagnostic tool."Hum Pathol.. 34. 89-92 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Wang X.: "Specificity and functional characteristics of anti-HLA-A mAb LGIII-147.4.1 and LGIII-224.6.2"Tissue Antigens. 62. 139-148 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Oka M.: "Protein kinase C α associates with phospholipase D1 and enhances basal phospholipase D activity in a protein phosphorylation-independent manner in human melanoma cells."J Invest Dermatol.. 121. 69-76 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Wakamatsu K.: "Comparison of pheomelanin and its precursor 5-S-cysteinyldopa in the serum of melanoma patients."Melanoma Res.. 13. 357-367 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Maldonado JL.: "Detetminants of BRAF mutations in primary melaomas."J.Natl.Cancer Inst.. 95. 1878-1890 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 影下 登志郎: "今日の治療指針2003年版(山口、北原編)"医学書院. 2 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Kageshita T, Ishihara T, Tokuo H, Funasaka Y, Ichihashi M, Dong J, Nakajima M, Ono T.: "Widespread expression of parathyroid hormone-related peptide in melanocytic cell."Brit J Dermatol.. 148. 533-538 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takata M, Maruo K, Kageshita T, Ikeda S, Ono T, Bastian BC.: "Two cases of unusual acral melanocytic tumors : Demonstration of molecular cytogenetics as a diagnostic tool."Hum Pathol.. 34. 89-92 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Kageshita T, Inoue Y, Ono T.: "Spontaneous regression of congenital melanocytic nevi without evidence of halo phenomenon."Dermatology. 207. 193-195 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Wang X, Liang B, Rebmann V, Lu J, Celis E, Kageshita T, Gross-Wilde H, Ferrone S.: "Specificity and functional characteristics of anti-HLA-A mAb LGIII-147.4.1 and LGIII-220.6.2"Tissue Antigens. 62. 139-148 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ryuke Y, Mizuno M, Natsume A, Suzuki O, Nobayashi M, Kageshita T, Matsumoto K, Saida T, Yoshida J.: "Growth inhibition of subcutaneous mouse melanoma and induction of natural killer cells by liposome-mediated interferon-beta gene therapy."Melanoma Res.. 13. 349-356 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Oka M, Kageshita T, Ono T, Goto A, Kuroki T, Ichihashi M.: "Protein kinase C α associates with phospholipase D1 and enhances basal phospholipase D activity in a protein phosphorylation-indepemdent manner in human melanoma cells."J Invest Dermatol.. 121. 69-76 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Wakamatsu K, Yokochi M, Naito A, Kageshita T, Ito S.: "Comparison of pheomelanin and its precursor 5-S-cysteinyldopa in the serum of melanoma patients."Melanoma Res.. 13. 357-363 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ishihara T, Kageshita T, Matsushita S, Ono T.: "Investigation of sentinel lymph nodes of the axillary and cubital regions in upper-extremity malignant skin tumors : a series of 15 patients."Int.J.Clin.Oncol.. 8. 297-300 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T, Ono T, Albertson DG, Pinkel D, Bastian BC.: "Deretminants of BRAF mutations in primary melaomas."J.Natl.Cancer Inst.. 95. 1878-1890 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Kageshita T.: "Widespread expression of parathyroid hormone-related peptide in melanocytic cell"Brit J Dermatol.. 143. 533-538 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Takata M.: "Two cases of unusual acral melanocytic tumors : Demonstration of molecular cytogenetics as a diagnostic tool"Hum Pathol.. 34. 89-92 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Wang X.: "Specificity and functional characteristics of anti-HLA-A mAb LGIII-147.4.1 and LGIII-220.6.2"Tissue Antigens. 62. 139-148 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Oka M.: "Protein kinase C α associates with phospholipase D1 and enhances basal phospholipase D activity in a protein phosphorylation-indepemdent manner in human melanoma cells"J Invest Dermatol.. 121. 69-76 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Wakamatsu K.: "Comparison of pheomelanin and its precursor 5-S-cysteinyldopa in the serum of melanoma patients"Melanoma Res.. 13. 357-367 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Maldonado JL.: "Deretminants of BRAF mutations in primary melaomas"J.Natl.Cancer Inst.. 95. 1878-1890 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 影下 登志郎: "今日の治療指針2003年版、山口、北原編"医学書院. 2 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Wakamatsu, K.: "Evaluation of 5-S-cysteinyldopa as a marker of melanoma progression : 10 years' experience"Melanoma Res.. 12. 245-253 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Kageshita T.: "Differential expression of tissue factor and tissue factor pathway inhibitor in metastatic melanoma lesions"Pigment Cell Res. 15. 212-216 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Kageshita T.: "Possible role of Galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance"Int J Cancer,. 99. 809-816 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Nobayashi, M.: "Repeated cationic lipsome-mediated gene transfer enhanced transduction efficacy against murine melanoma cell lines"J. Dermatol Sci.. 29. 206-213 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Takata, M.: "Two cases of unusual acral melanocytic tumors: Usefulness of comparative genomic hybridization (CGH) analysis in the differential diagnosis between Spitz nevus and acral melanoma"Human Pathol. (In press).

    • Related Report
      2002 Annual Research Report
  • [Publications] Kageshita, T.: "Spontaneous regression of congenital melanocytic nevi without evidence of halo phenomenon"Dermatology. (In press).

    • Related Report
      2002 Annual Research Report
  • [Publications] 影下登志郎: "腫瘍免疫<メラノーマ>やさしい皮膚免疫学 免疫学かたみた皮膚疾患、西岡編"医療ジャーナル社. 11 (2002)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi